R/C BUDEPRESS 200: Inhaler for Asthma and COPD Management

R/C BUDEPRESS 200

Budesonoid (200mcg) + Formoterol (0.6mcg)

R/C BUDEPRESS 200 combination of Budesonoid (200mcg) + Formoterol (0.6mcg) is a combination inhaler used to manage asthma and chronic obstructive pulmonary disease (COPD). This combination offers both anti-inflammatory and bronchodilator effects, providing comprehensive relief from respiratory symptoms.

What is Budesonoid (200mcg)?

Budesonoid is a corticosteroid that helps reduce inflammation in the airways, making it easier to breathe and preventing asthma attacks.

• Primary Uses

  • Long-term management of asthma.
  • Treatment of COPD to reduce inflammation.

• Key Benefits

  • Reduces inflammation in the airways.
  • Decreases the frequency and severity of asthma attacks.
  • Improves overall lung function and breathing.

• Dosage and Administration

  • Inhaled as directed by a healthcare provider.
  • Typically used twice daily.
  • Must be used regularly for best results.

• Possible Side Effects

  • Common: Throat irritation, hoarseness, coughing.
  • Serious: Allergic reactions, adrenal suppression (rare).

What is Formoterol (0.6mcg)?

Formoterol is a long-acting beta2-adrenergic agonist (LABA) that helps relax the muscles around the airways, making breathing easier.

• Primary Uses

  • Management of asthma and COPD.
  • Prevention of exercise-induced bronchospasm.

• Key Benefits

  • Provides long-lasting bronchodilation.
  • Rapid onset of action within minutes.
  • Reduces symptoms of wheezing and shortness of breath.

• Dosage and Administration

  • Inhaled as prescribed by a healthcare provider.
  • Usually administered twice daily.
  • Consistent use is essential for maintaining control over symptoms.

• Possible Side Effects

  • Common: Headache, tremors, nervousness.
  • Serious: Increased heart rate, chest pain, high blood pressure (rare).

R/C BUDEPRESS 200:

Dual Action Relief

R/C BUDEPRESS 200 combines Budesonoid and Formoterol to provide a dual-action approach for managing asthma and COPD.

• Enhanced Benefits

  • Combines anti-inflammatory and bronchodilator effects.
  • Reduces the need for multiple inhalers.
  • Convenient and effective for long-term management.

• Precautions

  • Always consult your healthcare provider before starting R/C BUDEPRESS 200.
  • Inform your doctor of any other medications or supplements you are taking.
  • Regular follow-ups are necessary to monitor your condition and adjust dosages.

Conclusion:

R/C BUDEPRESS 200, combining Budesonoid (200mcg) and Formoterol (0.6mcg), offers a comprehensive solution for managing asthma and COPD. Its dual-action formula not only alleviates symptoms but also improves overall respiratory health. Consult your healthcare provider to determine if R/C BUDEPRESS 200 is the right choice for you.Steris Healthcare Pvt Ltd, established in February 2018 by seasoned professionals in the pharmaceutical sector, operates under the name Sterispharma. Headquartered in Navi Mumbai, the company is certified by WHO, GMP, and ISO. Sterispharma is dedicated to providing high-quality medications at affordable prices across India, adhering to stringent WHO guidelines. They offer an online pharmacy platform for easy medicine purchases and home delivery. The company's mission is to deliver a diverse range of healthcare products catering to the varied needs of the medical community. From advanced treatments and rare condition medications to essential health supplies, Sterispharma aims to meet the extensive demands of the healthcare industry. Their product range covers numerous health fields, including Cardiology, Asthma, Respiratory issues, Nasal conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental care, and Dermatology.

For further information: 

EMAIL:  info@sterispharma.com  / contact@sterispharma.com   

CALL/WHATSAPP: 7877551268, 7849827488

BUY NOW